Biotech

All Articles

Lundbeck slashes worth of $250M Abide buyout after pain setback

.Lundbeck is actually reducing guide market value of its own $250 million Abide Therapeutics acquist...

Real- Globe Data Fulfills Professional Trial Concept: Improving Process and also Web Site Variety

.The combination of real-world information (RWD) right into procedure workability and also website s...

Where are they today? Catching up with past Fierce 15 honorees

.At this year's Fierce Biotech Peak in Boston, our team overtook innovators in the biotech business ...

Merck buys preclinical DNA biotech for $1.3 B biobucks

.Merck &amp Co. is actually taking down $30 million beforehand to acquire Yale spinout Modifi Biosci...

Radiopharma Alpha-9 elevates $175M series C to fund scientific press

.Alpha-9 Oncology has increased a $175 million series C round to stake its clinical-stage radiopharm...

Ocuphire to enhance in to genetics therapy biotech using Piece acquistion

.Eye medication producer Ocuphire Pharma is actually getting genetics therapy developer Piece Genes ...

Roche culls hack applicant, rotates KRAS program in Q3 improve

.Roche's chronic cough course has faltered to a standstill. The drugmaker, which axed the program af...

Merck- Gilead long-acting dental combo subdues HIV for 48 weeks

.Gilead Sciences and Merck &amp Co. have actually assisted their once-weekly HIV mixture treatment p...

Lykos takes FDA look at that MDMA authorization counts on new test

.Lykos Therapies might possess shed three-quarters of its own staff in the wake of the FDA's rejecti...

Septerna intends $158M IPO to finance readouts for GPCR pipe

.Septerna may be yet to divulge "any significant scientific data," but the biotech plainly thinks th...